Breast cancer in Norway 1970-1993: a population-based study on incidence, mortality and survival. by Wang, H. et al.
British Joumal ofCancer (1998) 77(9), 1519-1524
© 1998 Cancer Research Campaign
Breast cancer in Norway 1970-1993: a population-based
study on incidence, mortality and survival
H Wang, S0 Thoresen and S Tretli
The Cancer Registry of Norway, Institute for Epidemiological Cancer Research; Montebello, N-0310 Oslo, Norway
Summary The incidence, mortality and survival of breast cancer patients from 1970 to 1993 were studied using data from the Cancer
Registry of Norway. The age-adjusted incidence rate increased from 62.0 to 76.9 per 100 000 person-years during the period, and more than
2000 cases are now registered annually. The increase tends to be highest in the age group below 40 years. The increase is mainly found in
cases with localized tumours atthe time of diagnosis. The mortality rate has been almost unchanged in the period; the age adjusted mortality
rate is 27.0 per 100 000 person-years at the end of the study period. The 5-year overall survival has increased among cases with axillary
lymph node metastases at the time of diagnosis; the other stages show only little improvement.
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In 1985, the worldwide incidence of breast cancer was estimated
to be 720 000 new cases per year, 422 000 in developed countries
and 298 000 in developing countries (Parkin et al, 1993). Breast
cancer was third in frequency when both sexes were considered
together and by far the most important cancer in women (19% of
the diagnosis). The incidence rates are increasing in all countries
with available statistics, and its impact is magnified because
women are at risk from their late thirties. The incidence rates of
breast cancer are in general much higher in developed countries
than in developing countries; the highest incidence rates are found
in North America. In Norway, breast cancer contributed 22.4% of
female cancer diagnosis in 1993 (The Cancer Registry ofNorway,
1996). Although several risk factors are known, the understanding
of breast cancer aetiology is limited. Most of the known risk
factors are associated with less than a twofold increase in risk, and
breast cancer development is probably a process in which several
factors act together.
Mortality rates have generally been increasing worldwide, but
the increase is now reported to have declined in several western
countries (Hermon and Beral, 1996). This may be explained by
earlier detection, better treatment regimes or less aggressive
biological behaviour of the tumours. Studies have shown signifi-
cant mortality reduction by routine mammographic examination of
women aged 50-69 years (Nystr0m et al, 1993). Thus, screening
programmes have been organized in several European countries.
The aim ofthis study is to describe and analyse the trends ofbreast
cancer incidence in Norway in different age groups and stages
together with mortality trends and 5-year relative survival. A large
screening project was recently (1996) started in Norway among
women aged 50-69 years. It is therefore of interest to analyse
breast cancer data in Norway before organized screening was
started.
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MATERIALS AND METHODS
The reporting of cancer to the Cancer Registry (CR) of Norway
has been compulsory since the registry was established in 1952.
The reporting system is based on pathology and cytology reports,
clinical records and death certificates. This multiple reporting
practice provides an accurate and complete set of data for each
patient. Site, histological type, stage of disease at the time of
diagnosis, residence and the 11-digit individual identification
number allocated to every resident of Norway are reported. The
present study is based on 39 006 cases ofbreast cancer registered
from 1970 to 1993.
Incidence and mortality rates are given as rates per 100 000
person-years. The direct method of age standardization with
respect to the European standard population was used. The cases
were organized into successive 10-year age groups (20-29, 30-39,
... 80 +) and 5-year diagnostic periods where possible. Trends in
incidence and mortality rates for 1970-1993 were analysed by
fitting a log-linear function. This model was chosen because the
curves describe monotonically increasing functions. To have
enough data in all groups, the youngest mortality age group was
defined as 0-49 years.
Clinical staging was done at the time ofdiagnosis. According to
CancerRegistry definitions, the cases were organized into the clin-
ical stages 1, 2, 3, 4 and 9. Stage 1, tumours ofall sizes confined to
the breast (except cases belonging to stage 3); stage 2, tumour in
the breast with metastases to the axillary lymph nodes; stage 3,
tumour in the breast with direct extension to the skin or chest wall
(with or without axillary lymph node metastases); stage 4, tumour
in the breast with distant metastases; stage 9, unknown. The
unknown cases (stage 9) are not included in the statistical
analyses, because this small group is a mixture ofthe other stages.
A multivariate analysis of the 5-year survival was conducted
using a model described by Hakulinen and Tenkanen (1987). To
have enough data in all groups in this analysis, the youngest age
group was defined as 0-39 years. The model was fitted using the
GLIM statistical package. The relative risk (RR) of death within 5
years and its 95% confidence interval were computed for each
prognostic variable.
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Figure 1 Age-adjusted incidence (-+-) and mortality (--a-) rates in Norway
1970-1993
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Period of diagnosis
Figure 2 Stage-specific incidence rates in Norway 1970-1993. (+-),
Stage 1; (-*-), stage 2; (-*), stage 3; (-@-), stage 4; (- +*v -), stage 9
Table 1 Incidence of breast cancer per 10000 person-years in Norway 1970-1993 by age and period of diagnosis
Period 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993 Estimated percentage 95% Cl
annual increase
Age group (years)
0-19 0.0 0.0 0.0 0.1 0.0 - -
20-29 2.5 2.5 3.2 2.6 3.6 1.8 (0.0, 3.6)
30-39 26.4 29.7 32.4 31.0 35.9 1.4 (0.7, 2.2)
40-49 100.7 99.1 101.7 107.7 119.4 0.9 (0.4,1.3)
50-59 121.7 139.1 130.7 136.9 148.7 0.8 (0.3,1.2)
60-69 158.8 172.8 180.8 190.3 191.5 1.0 (0.7,1.3)
70-79 188.0 221.7 238.9 244.7 248.6 1.3 (1.0,1.7)
80+ 226.6 244.9 272.1 289.1 281.2 1.2 (0.7,1.7)
Crude rate 66.0 74.0 79.0 84.5 89.2
Age adjusted 62.0 68.0 69.8 72.9 76.9 1.0 (0.8,1.2)
Number of cases/year 1309 1509 1643 1792 1932
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Table 2 Incidence numbers by period of diagnosis and stage
Period 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993
n(%) n(%) n(%) n(%) n(%)
Stage
1 3262 (49.8) 4060 (53.8) 4640 (56.5) 5152 (57.5) 4525 (58.5)
2 2080 (31.8) 2205 (29.2) 2458 (29.9) 2634 (29.4) 2328 (30.1)
3 485 (7.4) 579 (7.7) 464 (5.7) 429 (4.8) 254 (3.3)
4 558 (8.5) 580 (7.7) 526 (6.4) 630 (7.0) 507 (6.6)
9 164 (2.5) 122 (1.6) 131 (1.6) 116 (1.3) 119 (1.5)
Total 6549 (100.0) 7546 (100.0) 8219 (100.0) 8961 (100.0) 7733 (100.00)
Table 3 Proportion of tumours at different stages and age groups in the periods 1970-1974 and 1990-1993
Period 1970-1974 1990-1993
Stage 1 2 3 4 9 1 2 3 4 9
%(n) %(n) %(n) %(n) %(n) %(n) %(n) %(n) %(n) %(n)
Age groups (years)
0-39 52.0 (157) 39.4 (119) 4.0 (12) 4.6 (14) 3.0 (5) 50.4 (245) 41.2 (200) 1.4 (7) 7.0 (34) 1.7 (2)
40-49 53.5 (585) 36.5 (399) 4.8 (53) 5.2 (57) 10.9 (18) 55.1 (761) 37.9 (523) 1.6 (22) 5.4 (74) 7.8 (9)
50-59 47.6 (703) 36.4 (538) 6.4 (94) 9.6 (142) 12.1 (20) 56.1 (651) 36.0 (418) 1.8 (21) 6.1 (70) 6.1 (7)
60-69 49.2 (797) 34.4 (558) 8.0 (129) 8.4 (136) 20.6 (34) 56.7 (877) 33.0 (510) 2.9 (45) 7.4 (115) 9.6 (11)
70+ 53.9 (1020) 24.6 (466) 10.4 (197) 11.1 (209) 53.4 (88) 64.9 (1982) 22.6 (690) 5.3 (161) 7.2 (221) 74.8 (86)
The urban/rural status is defined by 'Statistics Norway' on the
basis of administrative areas. The difference between urban and
rural incidence and mortality rates was analysed by dividing the
study period into two periods: 1970-1981 and 1982-1993.
RESULTS
Incidence
The age-adjusted incidence and mortality curves are shown in
Figure 1. The average annual number of breast cancer cases
increased from 1309 in the period 1970-1974 to 1932 in the period
1990-1993, a 47% increase (Table 1). There is an increasing inci-
dence rate in all age groups during the whole study period. The
annual age-adjusted increase in the incidence rate is estimated at
1.0% (Table 1). The increase tends to be higher in the youngest (<
40 years) and oldest (> 70 years) age groups. In the latest decade
(1984-1993), the annual increases were estimated to be 3.3%,
2.7% and 2.2% for the age groups 0-29, 30-39 and 40-49 years
respectively (data not shown).
Stage-specific incidence rates by period are illustrated in Figure
2, and absolute numbers are presented in Table 2. Table 3 presents
the proportion of tumours at different stages and ages in the
periods 1970-1974 and 1990-1993. The increasing incidence is
mainly found in stage 1; the total number of cases in stage 1
increased from 3262 in 1970-1974 to 5152 in 1985-1989. In
women older than 80 years, 65.4% were diagnosed as stage 1 in
1985-1989. This is an increase of more than 12% since
1970-1974. The number of cases in this age group increased from
342 to 930 in the two periods.
The urban/rural analysis reveals that the age-adjusted relative
incidence rate tends to be almost unchanged, with an urban domi-
nance decreasing only from 1.21 to 1.16. Among women below 40
years, there was no difference in urban/rural incidence rates in
1982-1993, indicating that the increase in incidence has been
higher in rural than in urban areas.
Mortality
The age-adjusted mortality rate is practically unchanged during the
study period (Figure 1), with an estimated yearly increase of0.5%.
There is a small reduction in the age group 50-59 years (- 0.6%),
whereas the mortality rates increase most among women above 80
years (1.6%) (Table 4). The urban/rural analysis (data not shown)
reveals that the relative mortality rate tends to be almost
unchanged, with an urban dominance decreasing from 1.17 to
1.10. Among women under 60 years, no difference was found in
urban/rural incidence rates in 1982-1993.
Survival
The 5-year relative survival rates by age and stage in the two
periods 1970-1974 and 1985-1989 are shown in Table 5. The
survival rates in stage 2 have increased for all ages; the other
stages show only little improvement. The highest 5-year survival
rate, 90.8%, is found in the age group 40-49 years diagnosed as
stage 1 in the latest period.
The multivariate analysis with three variables (age, stage and
period) gave an acceptable fit. The estimates of relative risk (RR)
ofdeath within 5 years and their95% confidence interval are given
in Table 6. As expected, stage at time ofdiagnosis was found to be
the most important prognostic factor. All age groups are found to
have slightly higher RR than the reference group 40-49 years. The
RR is reduced by 20% in the latest period, indicating a better
overall survival.
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Table 4 Mortality of breast cancer per 100 000 person-years in Norway 1970-1993 by age and period of diagnosis
Period 1970-1974 1975-1979 1980-1984 1985-1989 1990-1993 Estimated percentage annual 95% Cl
increase
Age group (years)
0-49 5.1 4.4 4.2 5.8 7.0 1.8 (0.2, 3.3)
50-59 52.9 54.9 50.6 52.1 45.2 -0.6 (-1.0, -0.2)
60-69 67.5 77.1 73.3 74.8 76.3 0.4 (-0.1, 0.9)
70-79 89.4 100.3 106.6 112.1 107.7 1.1 (0.4,1.8)
80+ 132.9 145.1 153.9 175.6 177.3 1.6 (1.1, 2.1)
Crude rate 27.3 30.3 31.0 34.3 34.3
Age adjusted 24.4 25.9 25.1 27.0 26.4 0.5 (0.2, 0.7)
Number of cases/year 541 618 645 727 746
Table 5 Five-year relative survival rates (%) in patients with breast cancer in Norway, by stage, age and period of diagnosis
Period 1970-1974 1985-1989
Stage 1 2 3 4 1 2 3 4
Age groups (years)
0-39 85.3 54.2 33.3 28.6 87.3 59.8 40.0 21.7
40-49 90.4 63.8 47.2 21.1 90.8 68.9 46.7 13.6
50-59 82.3 55.9 45.7 7.7 85.7 62.0 52.9 7.4
60-69 80.4 51.0 46.5 9.7 85.3 66.1 64.9 11.8
70+ 53.0 37.3 29.6 10.1 58.6 50.4 34.4 11.4
Table 6 Relative risk (RR) of death within 5 years and 95% confidence
intervals in breast cancer patients according to stage, period of diagnosis
and age
Variable RR 95% Cl
Age group (years)
0-39 1.4 (1.1,1.7)
40-49 1.0 Reference group
50-59 1.3 (1.1,1.6)
60-69 1.1 (1.0,1.4)
70+ 1.2 (1.0,1.5)
Stage
1 1.0 Reference group
2 3.7 (3.2, 4.3)
3 5.2 (4.2, 6.4)
4 16.1 (13.5, 19.1)
Period
1970-1974 1.0 Reference group
1985-1989 0.8 (0.7, 0.9)
DISCUSSION
In the present study, all cases of breast cancer reported to the
Cancer Registry of Norway during 1970-1993 were subjected to
an analysis ofincidence, mortality and survival. The completeness
of the Cancer Registry data, both on diagnosis and on cause of
death, make the data reliable. The main finding in this study is the
increasing incidence rate during the whole study period, estimated
to be 1.0% yearly. Estimates of annual increase are higher for the
last decade than for the whole study period. Increasing incidence
rates are reported in Denmark and Iceland before organized
mammography screening (Andreasen et al, 1994; Sigurdsson et al,
1991). Some studies from the USA (Newcomb and Lantz, 1993;
Garfinkel et al, 1994) show declining incidence rates since the late
1980s after several years ofincreasing incidence. This is probably
due to more years of extended use of mammography in asympto-
matic women. Norway, however, has had no organized screening
programme for breast cancer during the study period. Still, the
yearly number ofmammograms taken unorganized in Norway has
increased from 10000 in 1983 to 220 000 in 1993 (Widmark and
Olsen, 1995). Most of these mammograms were taken among
younger women (therefore at lower risk) living in urban areas.
We found that incidence rates are increasing in all age groups,
but the increase is most pronounced among women younger than
40 years. As the increase in these age groups is highest in rural
areas, this increase is probably not caused by extended use of
mammography. A similar trend in incidence among women
younger than 40 was not found in Sweden (Persson et al, 1998),
but our results confirm a previous report on incidence increase
among Norwegian women under 50 years in the period 1983-1993
(Matheson and Tretli, 1996). A transient incidence increase
reported among Swedish women aged 50-69 years is most prob-
ably the result of mammographic screening (Persson et al, 1998).
It will be interesting to see if the ongoing Norwegian screening
project will cause a similar transient incidence increase among
women aged50-69 years. A Danish study (Andreasen et al, 1994),
before mammographic screening, reports that the largest increase
in incidence was found among women younger than 60 years. In
some countries of low incidence, such as Japan, the rise in inci-
dence has so far been observed predominantly in women under
the age of 50 years and appears to be a birth cohort effect (Miller
and Bulbrook, 1986). Lower breast cancer incidence rates than
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expected are reported among Norwegian women who experienced
their adolescence during World War II (Tretli and Gaard, 1996).
This birth cohort effect implies that one or more lifestyle factors
that changed among adolescent women during the war influenced
their risk ofbreast cancer. There is an increasing awareness of the
importance ofthe period between menarche and first birth (Colditz
and Frazier, 1995). Factors such as adolescence nutrition (Tretli
and Gaard, 1996) and regular physical exercise (Bernstein et al,
1994) are thought to have an impact on later risk of developing
breast cancer, but more studies are required on the possible impact
ofteenage lifestyle on breast cancer risk.
Attention has focused an environmental and dietary oestrogens
as possible contributors to the increased incidence ofbreast cancer
but the epidemiological findings are inconclusive (Ahlborg et al,
1995; Safe, 1995). However, even though the total amount of
environmental and dietary oestrogen is low, it might have an influ-
ence over time, especially in adolescent women. It is well known
that a woman's reproductive history affects her risk of breast
cancer (Kv'ale et al, 1987; Kvale and Heuch, 1987). The delayed
child-bearing pattern that is seen in most western countries is
another factor that may contribute to a woman's total risk ofdevel-
oping breast cancer. These factors may be contributors to the
observed increase in incidence rates among younger women. It is
interesting to notice that the difference between urban and rural
areas is decreasing and, among younger women, no difference in
incidence rate is found in the latest period. This may be explained
by the fact that rural lifestyle, including nutrition, has changed
towards that in urban areas.
Our data reveal an excess increase in incidence rates among
older women (above 70 years). This may be explained by an
increasing proportion of very elderly women together with
increased breast cancer awareness. The increase in incidence in
stage 1 diagnosis is especially high in this age group, but this is
probably an artifact caused by less extensive examination of axil-
lary lymph nodes among older patients.
The role of stage 1 diagnosis is increasing (Figure 2 and Table
3). There may be several reasons for this increase in stage 1 diag-
nosis, for instance early detection or change in tumour biology.
Mammography of asymptomatic women is a method that causes
stage migration towards stage 1, but in Norway most women
detect their breast cancer themselves. The increased breast cancer
awareness in general and instruction in self-palpation have caused
women to visit their doctor earlier, thus getting their diagnosis at a
stage with better prognosis. It is likely, however, that as a result of
the ongoing large screening project, the part of stage 1 diagnosis
will continue to increase in the age group 50-69 years. One may
speculate that change in some environmental factors initiates
tumour development more easily than before, but that the tumours
are less aggressive and remain longer in stage 1. A tendency for
oral contraceptive users to have more localized tumours than never
users has been reported (Collaborative group on Hormonal Factors
in Breast Cancer, 1996) and perhaps other factors such as xeno-
oestrogens have a similar effect.
The possibility has been raised that lesions that would remain
benign are now being diagnosed and treated as cancer. If so, we
would have expected a more pronounced improvement in 5-year
survival among the stage 1 cases. It is, therefore, more likely that
the cases diagnosed would develop into stages with poorer prog-
nosis ifnot treated properly.
We find that the mortality rate is practically unchanged in the
study period. It is interesting to note that the Scandinavian countries
(which all have complete cancer registers) report different mortality
trends. Denmark reports an unchanged mortality rate, as in this
study (Ewertz and Carstensen, 1988). In Finland, the mortality was
increasing until 1985, whereas Sweden has had a small decline
since 1975 (Hermon and Beral, 1996). It is difficult to explain
which differences in lifestyle or health system might cause these
different mortality trends, although nutrition and use of mammog-
raphy could be among relevant factors.
As expected, stage at time of diagnosis is found to be the most
important factor influencing the relative risk of death within 5
years. The multivariable analysis shows that this risk has signifi-
cantly reduced during the study period by 20% (Table 6), indi-
cating better survival especially in stage 2, probably as a result of
better treatment. This is also reflected in the 5-year survival rates
in Table 5. In the 1970s, surgery and radiation were the main treat-
ment regimes, whereas chemotherapy has played a larger role in
recent years. The use of such treatment and hormones have prob-
ably had a positive impact on survival.
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